Syros Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Syros Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 33% to $9,936,000. Profit margin reached -1656%. Total operating expenses were $138,924,000.
Profit Margin
| 2014 | 0 | -13.43M | |
|---|---|---|---|
| 2015 | 317K | -29.81M | -9406.31% |
| 2016 | 317K | -47.74M | -15060.88% |
| 2017 | 1.10M | -54.01M | -4905.54% |
| 2018 | 2.05M | -62.27M | -3038% |
| 2019 | 1.98M | -75.43M | -3806.16% |
| 2020 | 15.09M | -85.83M | -568.67% |
| 2021 | 23.48M | -90.46M | -385.15% |
| 2022 | 14.88M | -49.30M | -331.32% |
| 2023 | 9.93M | -164.57M | -1656.34% |
SYRS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 9.93M | 14.88M | 23.48M | 15.09M | 1.98M | 2.05M | 1.10M | 317K | 317K | 0 |
Cost of revenue | 2.25M | 2.96M | 0 | 0 | 0 | 0 | 1.52M | 0 | 602K | 0 |
Gross profit | 7.68M | 11.91M | 23.48M | 15.09M | 1.98M | 2.05M | -426K | 317K | -285K | 0 |
Operating exp. | ||||||||||
Research and development | 108.15M | 111.94M | 99.87M | 76.06M | 58.24M | 50.18M | 41.89M | 37.81M | 24.40M | 10.92M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 138.92M | 141.24M | 122.90M | 97.39M | 79.72M | 66.34M | 55.78M | 48.28M | 30.13M | 13.43M |
Operating income | -128.98M | -135.87M | -99.42M | -82.29M | -77.74M | -64.29M | -54.68M | -47.96M | -29.82M | -13.43M |
Other income (expenses), net | -35.58M | 41.21M | 12.86M | -1.74M | 2.30M | 2.01M | 676K | 220K | 2K | 4K |
Income before tax | -164.57M | -94.65M | -86.55M | -84.03M | -75.43M | -62.27M | -54.01M | -47.74M | -29.81M | -13.43M |
Income tax expense | 0 | -45.35M | 3.90M | 1.79M | 0 | 2.01M | -1.52M | 0 | 0 | 0 |
Net income | -164.57M | -49.30M | -90.46M | -85.83M | -75.43M | -62.27M | -54.01M | -47.74M | -29.81M | -13.43M |
Earnings per share | ||||||||||
Basic EPS | -5.81 | -3.9 | -14.47 | -18.64 | -18.76 | -19.07 | -21.26 | -37.6 | -120.45 | -54.25 |
Diluted EPS | -5.81 | -3.9 | -14.47 | -18.64 | -18.76 | -19.07 | -21.26 | -37.6 | -120.45 | -54.25 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |